Loss of estrogen upregulates osteoblastogenesis in the murine bone marrow evidence for autonomy from factors released during bone resorption

Journal of Clinical Investigation

Volumn 101, Issue 9, 1998, Pages 1942-1950

  Jilka, Robert L ^b   Takahashi, Kenshiro ^b   Munshi, Medha ^b   Williams, Daniel C ^a   Roberson, Paula K ^b   Manolagas, Stavros C ^b  

^a ELI LILLY AND COMPANY   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Bone remodeling; Estrogen deficiency; Osteoblast formation; Osteoclast formation; Postmenopausal osteoporosis

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE REMODELING; ESTROGEN METABOLISM; FEMALE; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOLYSIS; OVARIECTOMY; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL;

EID: 0032080656     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI1039     Document Type: Article

References (46)

1. Aubin, J.E., K. Turksen, and J.N.M. Heersche. 1993. Osteoblastic cell lineage. In Cellular and Molecular Biology of Bone. M. Noda, editor. Academic Press, San Diego, CA. 1-45.
2. Roodman, G.D. 1996. Advances in bone biology: the osteoclast. Endocr. Rev. 17:308-332.
3. Bellows, C.G., J.E. Aubin, and J.N.M. Heersche. 1991. Initiation and progression of mineralization of bone nodules formed in vitro: the role of alkaline phosphatase and organic phosphate. Bone Miner. 14:27-40.
4. Van Vlasselaer, P., N. Falla, H. Snoeck, and E. Mathieu. 1994. Characterization and purification of osteogenic cells from murine bone marrow by two-color cell sorting using anti-Sca-1 monoclonal antibody and wheat germ agglutinin. Blood. 84:753-763.
5. Suda, T., N. Takahashi, and T.J. Martin. 1992. Modulation of osteoclast differentiation. Endocr. Rev. 13:66-80.
6. Parfitt, A.M., C.H.E. Mathews, A.R. Villanueva, M. Kleerekoper, B. Frame, and D.S. Rao. 1983. Relationships between surface, volume and thickness of iliac trabecular bone in aging and in osteoporosis: implications for the microanatomic and cellular mechanism of bone loss. J. Clin. Invest. 72:1396-1409.
7. Eriksen, E.F., S.F. Hodgson, R. Eastell, S.L. Cedel, W.M. O'Fallon, and B.L. Riggs. 1990. Cancellous bone remodeling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels. J. Bone Miner. Res. 5:311-319.
8. Poli, V., R. Balena, E. Fattori, A. Markatos, A. Yamamoto, H. Tanaka, G. Ciliberto, G.A. Rodan, and F. Costantini. 1994. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO (Eur. Mol. Biol. Organ.) J. 13:1189-1196.
9. Balena, R., B.C. Toolan, M. Shea, A. Markatos, E.R. Myers, S.C. Lee, E.E. Opas, J.G. Seedor, H. Klein, D. Frankenfield, et al. 1993. The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates. J. Clin. Invest. 92:2577-2586.
10. Kalu, D.N. 1991. The ovariectomized rat model of postmenopausal bone loss. Bone Miner. 15:175-192.
11. Jilka, R.L., G. Hangoc, G. Girasole, G. Passeri, D.C. Williams, J.S. Abrams, B. Boyce, H. Broxmeyer, and S.C. Manolagas. 1992. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science. 257: 88-91.
12. Bellido, T., R.L. Jilka, B.F. Boyce, G. Girasole, H. Broxmeyer, S.A. Dalrymple, R. Murray, and S.C. Manolagas. 1995. Regulation of interleukin-6, osteoclastogenesis and bone mass by androgens: the role of the androgen receptor. J. Clin. Invest. 95:2886-2895.
13. Girasole, G., R.L. Jilka, G. Passeri, S. Boswell, G. Boder, D.C. Williams, and S.C. Manolagas. 1992. 17β-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in-vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J. Clin. Invest. 89:883-891.
14. Pottratz, S.T., T. Bellido, H. Mocharla, D. Crabb, and S.C. Manolagas. 1994 17β-estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism. J. Clin. Invest. 93:944-950.
15. Ray, A., K.E. Prefontaine, and P. Ray. 1994. Down-modulation of interleukin-6 gene expression by 17 beta-estradiol in the absence of high affinity DNA binding by the estrogen receptor. J. biol. Chem. 269:12940-12946.
16. Stein, B., and M.X. Yang. 1995. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta. Mol. Cell Biol. 15:4971-4979.
17. Kassem, M., S.A. Harris, T.C. Spelsberg, and B.L. Riggs. 1996. Estrogen inhibits interleukin-6 production and gene expression in a human osteoblastic cell line with high levels of estrogen receptors. J. Bone Miner. Res. 11:193-199.
18. Galien, R., and T. Garcia. 1997. Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kappaB site. Nucleic Acids Res. 25:2424-2429.
19. Lin, S.-C., T. Yamate, Y. Taguchi, V.Z.C. Borba, G. Girasole, C.A. O'Brien, T. Bellido, E. Abe, and S.C. Manolagas. 1997. Regulation of the gp80 and gp130 subunits of the IL-6 receptor by sex steroids in the murine bone marrow. J. Clin. Invest. 100:1880-1890.
20. Delmas, P.D. 1993. Biochemical markers of bone turnover. J. Bone Miner. Res. 8:S549-S554.
21. Hughes, D.E., K.R. Wright, H.L. Uy, A. Sasaki, T. Yoneda, G.D. Roodman, G.R. Mundy, and B.F. Boyce. 1995. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J. Bone Miner. Res. 10:1478-1487.
22. Jilka, R.L., R.S. Weinstein, K. Takahashi, A.M. Parfitt, and S.C. Manolagas. 1996. Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence. J. Clin. Invest. 97:1732-1740.
23. Stuart, A., and J.K. Ord. 1987. Kendall's Advanced Theory of Statistics. Oxford Universitv Press, New York. 223.
24. Weinstein, R.S., R.L. Jilka, A.M. Parfitt, and S.C. Manolagas. 1997. The effects of androgen deficiency on murine bone remodeling and bone mineral density are mediated via cells of the osteoblastic lineage. Endocrinology. 138: 4013-4021.
25. Triffitt, J.T. 1996. The stem cell of the osteoblast. In Principles of Bone Biology. J.P. Bilezikian, L.G. Raisz, and G.A. Rodan, editors. Academic Press, San Diego. CA. 39-50.
26. Wronski, T.J., L.M. Dann, K.S. Scott, and M. Cintrön. 1989. Long-term effects of ovariectomy and aging on the rat skeleton. Calcif. Tissue Int. 45:360-366.
27. Li, M., Y. Shen, H. Qi, and T.J. Wronski. 1996. Comparative study of skeletal response to estrogen depletion at red and yellow marrow sites in rats. Anat. Rec. 245:472-480.
28. Stepan, J.J., A. Tesarova, T. Havranek, J. Jodl, J. Formankova, and V. Pacovsky. 1985. Age and sex dependency of the biochemical indices of bone remodeling. Clin. Chim. Acta. 151:273-283.
29. Most, W., L. Schot, A. Ederveen, L. Van der Wee-Pals, S. Papapoulos, and C. Löwik. 1995. In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis. J. Bone Miner. Res. 10:1523-1530.
30. Scutt, A., U. Kollenkirchen, and P. Bertram. 1996. Effect of age and ovariectomy on fibroblastic colony-forming unit numbers in rat bone marrow. Calcif. Tissue Int. 59:309-310.
31. Modrowski, D., L. Miravet, M. Feuga, and P.J. Marie. 1993. Increased proliferation of osteoblast precursor cells in estrogen-deficient rats. Am. J. Physiol. 264:E190-E196.
32. Manolagas, S.C., and R.L. Jilka. 1995. Mechanisms of disease: bone marrow, cytokines, and bone remodeling: emerging insights into the pathophysiology of osteoporosis. N. Engl. J. Med. 332:305-311.
33. Parfitt, A.M. 1992. The two-stage concept of bone loss revisited. Triangle. 31:99-110.
34. Eastell, R., P.D. Delmas, S.F. Hodgson, E.F. Eriksen, K.G. Mann, and B.L. Riggs. 1988. Bone formation rate in older normal women: concurrent assessment with bone histomorphometry, calcium kinetics, and biochemical markers. J. Clin. Endocrinol. Metab. 67:741-748.
35. Oreffo, R.O.C., G.R. Mundy, S.M. Seyedin, and L.F. Bonewald. 1989. Activation of the bone-derived latent TGF beta complex by isolated osteoclasts. Biochem. Biophys. Res. Commun. 158:817-823.
36. Hayden, J.M., S. Mohan, and D.J. Baylink. 1995. The insulin-like growth factor system and the coupling of formation to resorption. Bone. 17(Suppl):93S-98S.
37. Hattner, R., B.N. Epker, and H.M. Frost. 1965. Suggested sequential mode of control of changes in cell behavior in adult bone remodelling. Nature. 206:489-490.
38. van Beek, E.R., C.W. Löwik, and S.E. Papapoulos. 1997. Effect of alendronate treatment on the osteoclastogenic potential of bone marrow cells in mice. Bone. 4:335-340.
39. Manolagas, S.C., R.L. Jilka, T. Bellido, C.A. O'Brien, and A.M. Parfitt. 1996. Interleukin-6-type cytokines and their receptors. In Principles of Bone Biology. J.P. Bilezikian, L.G. Raisz, and G.A. Rodan, editors. Academic Press, San Diego, CA. 701-713.
40. Bellido, T., V.Z.C. Borba, P. Roberson, and S.C. Manolagas. 1997. Activation of the JAK/STAT signal transduction pathway by IL-6 type cytokines promotes osteoblast differentiation. Endocrinology. 138:3666-3676.
41. Taguchi, T., T. Yamate, H. Mocharla, S.-C. Lin, A. Vertino, P. DeTogni, E. Abe, and S.C. Manolagas. 1996. Interleukin-6 induces osteoblast differentiation in uncommitted embryonic fibroblasts (EF). J. Bone Miner. Res. 11: S101(Abstr.).
42. Metcalf, D., and D.P. Gearing. 1989. Fatal syndrome in mice engrafted with cells producing high levels of the leukemia inhibitory factor. Proc. Natl. Acad. Sci. USA. 86:5948-5952.
43. Malik, N., U.S. Haugen, B. Modrell, M. Shoyab, and C.H. Clegg. 1995. Developmental abnormalities in mice transgenic for bovine oncostatin M. Mol. Cell Biol. 15:2349-2358.
44. WAF1.C1P1 gene in osteoblasts: a prerequisite for the biologic effects of IL-6 type cytokines. J. Bone Miner. Res. 12:S159(Abstr.).
45. Jilka, R.L., R.S. Weinstein, T. Bellido, A.M. Parfitt, and S.C. Manolagas. 1998. Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines. J. Bone Miner. Res. In press.
46. Lin, S.-C., T. Yamate, Y. Taguchi, V.Z. Borba, G. Girasole, C.A. O'Brien, T. Bellido, E. Abe, and S.C. Manolagas. 1997. Regulation of the gp80 and gp130 subunits of the IL-6 receptor by sex steroids in the murine bone marrow. J. Clin. Invest. 100:1980-1990.